Antibiotic Prophylaxis for the Prevention of Infection after Major Limb Amputation

European Journal of Vascular and Endovascular Surgery

Volumn 37, Issue 6, 2009, Pages 696-703

  McIntosh, J ^a   Earnshaw, J J ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

Author keywords

Amputation; Antibiotic prophylaxis; Wound infection

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFRADINE; CEFUROXIME; FLUCLOXACILLIN; FLUMOXIL; METICILLIN; METRONIDAZOLE; NEOMYCIN; PENICILLIN G; PENICILLIN V; PLACEBO; TEICOPLANIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTERIOSCLEROSIS; BACTERIAL COLONIZATION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION PREVENTION; INFECTION RATE; LIMB AMPUTATION; LIMB ISCHEMIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPEATED DRUG DOSE; REVIEW; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT INDICATION; TREATMENT OUTCOME; ULCER HEALING; WOUND HEALING;

AMPUTATION; AMPUTATION STUMPS; ANTIBIOTIC PROPHYLAXIS; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; REOPERATION; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; WOUND HEALING;

EID: 67349171528     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.01.013     Document Type: Review

References (30)

1. Mangram A.J., Horan T.C., Pearson M.L., Silver L.C., and Jarvis W.R. Guideline for prevention of surgical site infection, 1999. Centers for disease control and prevention (CDC) hospital infection control practices advisory committee. Am J Infect Control 27 2 (1999) 97-132
2. Rubinovitch B., and Pittet D. Screening for methicillin-resistant Staphylococcus aureus in the endemic hospital: what have we learned?. J Hosp Infect 47 1 (2001) 9-18
3. Salgado C.D., Farr B.M., and Calfee D.P. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 36 2 (2003) 131-139
4. Briggs S., McGuiness C., Foster M., and Roberts S. A reservoir for methicillin-resistant Staphylococcus aureus in the Auckland community?. N Z Med J 115 1162 (2002) U182
5. Tacconelli E. New strategies to identify patients harbouring antibiotic-resistant bacteria at hospital admission. Clin Microbiol Infect 12 2 (2006) 102-109
6. Tacconelli E., Venkataraman L., De Girolami P.C., and Dagata E.M. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 53 3 (2004) 474-479
7. Huizinga W.K., Robbs J.V., Bhamjee A., and Kritzinger N.A. Wound infection after major lower-limb amputation - the role of antibiotic prophylaxis. S Afr J Surg 24 3 (1986) 98-102
8. Moller B.N., and Krebs B. Antibiotic prophylaxis in lower limb amputation. Acta Orthop Scand 56 4 (1985) 327-329
9. Norlin R., Fryden A., Nilsson L., and Ansehn S. Short-term cefotaxime prophylaxis reduces the failure rate in lower limb amputations. Acta Orthop Scand 61 5 (1990) 460-462
10. Sonne-Holm S., Boeckstyns M., Menck H., Sinding A., Leicht P., Dichmann O., et al. Prophylactic antibiotics in amputation of the lower extremity for ischemia. A placebo-controlled, randomized trial of cefoxitin. J Bone Joint Surg Am 67 5 (1985) 800-803
11. Thomsen S., Jakobsen B.W., Wethelund J.O., Dalsgaard J., Gregersen H.N., and Lucht U. Antibiotic prophylaxis in lower-extremity amputations due to ischemia. A prospective, randomized trial of cephalothin versus methicillin. Arch Orthop Trauma Surg 109 2 (1990) 72-74
12. Friis H. Penicillin G versus cefuroxime for prophylaxis in lower limb amputation. Acta Orthop Scand 58 6 (1987) 666-668
13. Huizinga W.K., Robbs J.V., and Kritzinger N.A. Prevention of wound sepsis in amputations by peri-operative antibiotic cover with an amoxycillin-clavulanic acid combination. S Afr Med J 63 3 (1983) 71-73
14. Barlow I.W., Ausobsky J.R., Wilkinson D., and Kester R.C. Controlled trial of cephradine versus cefuroxime in vascular surgery. Int J Clin Pharmacol Res 9 3 (1989) 223-227
15. Hares M.M., Downing R., and Marsh J. Failure of metronidazole/penicillin oral prophylaxis to prevent amputation stump infection. Lancet 1 8176 (1980) 1028-1029
16. Richards T., Pittathankel A.A., Pursell R., Magee T.R., and Galland R.B. MRSA in lower limb amputation and the role of antibiotic prophylaxis. J Cardiovasc Surg (Torino) 46 1 (2005) 37-41
17. Scriven J.M., Silva P., Swann R.A., Thompson M.M., Naylor A.R., Bell P.R., et al. The acquisition of methicillin-resistant Staphylococcus aureus (MRSA) in vascular patients. Eur J Vasc Endovasc Surg 25 2 (2003) 147-151
18. Grimble S.A., Magee T.R., and Galland R.B. Methicillin resistant Staphylococcus aureus in patients undergoing major amputation. Eur J Vasc Endovasc Surg 22 3 (2001) 215-218
19. Stewart A.H., Eyers P.S., and Earnshaw J.J. Prevention of infection in peripheral arterial reconstruction: a systematic review and meta-analysis. J Vasc Surg 46 1 (2007) 148-155
20. Earnshaw J.J. Methicillin-resistant Staphylococcus aureus: vascular surgeons should fight back. Eur J Vasc Endovasc Surg 24 4 (2002) 283-286
21. Naylor A.R., Hayes P.D., and Darke S. on behalf of the Joint Vascular Research Group. A prospective audit of complex wound and graft infection in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg 21 (2001) 289-294
22. Schelenz S., Tucker D., Georgeu C., Daly S., Hill M., Roxburgh J., et al. Significant reduction of endemic MRSA acquisition and infection in cardiothoracic patients by means of an enhanced targeted infection control programme. J Hosp Infect 60 2 (2005) 104-110
23. Clancy M., Graepler A., Wilson M., Douglas I., Johnson J., and Price C.S. Active screening in high-risk units is an effective and cost-avoidant method to reduce the rate of methicillin-resistant Staphylococcus aureus infection in the hospital. Infect Control Hosp Epidemiol 27 10 (2006) 1009-1017
24. Wilcox M.H., Hall J., Pike H., Templeton P.A., Fawley W.N., Parnell P., et al. Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 54 3 (2003) 196-201
25. Gemmell C.G., Edwards D.I., Fraise A.P., Gould F.K., Ridgway G.L., and Warren R.E. Guidelines for the prophylaxis and treatment of methicillin resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 57 (2006) 589-608
26. Coia J.E., Duckworth G.J., Edwards D.I., Farringdon M., Fry C., Humphreys H., et al. Guidelines for the control and prevention of methicillin resistant Staphylococcus aureus in healthcare facilities. J Hosp Infect 63 Suppl. I (2006) S1-S44
27. Antibiotic prophylaxis in surgery: a national clinical guideline (2008), Scottish Intercollegiate Guidelines Network. 978 1 905813 346 104
28. Sadat U., Chaudhuri A., Hayes P.D., Gaunt M.E., Boyle J.R., and Varty K. Five day antibiotic prophylaxis for major lower limb amputation reduces wound infection rates and the length of in-hospital stay. Eur J Vasc Endovasc Surg 35 1 (2008) 75-78
29. Nawaijn S.E., van der Linde H., Emmelot C.H., and Hofstad C.J. Stump management after trans-tibial amputation: a systematic review. Prosthet Orthot Int 29 (2005) 13-26
30. Tisi P.V., and Callam M.J. Types of incision for below knee amputation. Cochrane Database Syst Rev 1 (2004) CD003749 [Review]